Furthermore, when investigating the relationships between serum CEA and IGFBP‐3 levels, no relationships were found and the results indicated that serum IGFBP‐3 might be a complementary marker for CEA in CRC diagnosis. This evidence concerns the gene IGFBP3 and colorectal carcinoma.